Merghoub Taha

Merghoub Taha

Category : Medicine - Pharmacy - Veterinary science - Sport

MERGHOUB Taha

Merghoub_Taha-.jpg

Deputy Director and Cancer Immunology Researcher

Weill Cornell Medicine, United States

Origins & Education

Taha Merghoub was born and raised in Béni Izguen, a village in the wilaya of Ghardaïa, in the heart of the M'zab Valley in Algeria. The son of a physician, he was inspired by science and medicine from an early age, nurturing ambitions to dedicate himself to scientific research.

His schooling took place entirely within the Algerian public education system. After successful primary and secondary studies, he continued his education at Moufdi Zakaria High School, where he obtained his Science Baccalaureate in 1987.

Eager to deepen his knowledge, Taha Merghoub then went to Algiers to attend the University of Science and Technology Houari Boumediene (USTHB). There, he earned his Diploma of Higher Studies (DES) in genetics, marking the beginning of his scientific career. His first steps in research were particularly fruitful when he discovered a variant of hemoglobin D-Ouled Rabah, a finding that would later be published in the European Journal of Human Genetics.

Continuing his academic journey in France, he completed a master's degree in biology and applied genetics at the University of Paris 7, where he became interested in hepatic differentiation. His academic excellence enabled him to obtain a PhD in human genetics with the highest distinction from the University of Paris. His thesis focused on studying genetic polymorphism in the fetal hemoglobin gene in patients with sickle cell anemia and thalassemia. His findings provided valuable insight into the correlation between genotypes and phenotypes in these pathologies.

Scientific Career

After obtaining his doctorate, Taha Merghoub pursued his research career in the United States, where he conducted his postdoctoral research under the guidance of Dr. Pier Paolo Pandolfi at Memorial Sloan Kettering Cancer Center (MSK) in New York. During this period, he dedicated himself to characterizing the transcriptional properties of the ZBTB7 gene and studying its role during development. He also actively participated in creating laboratory models for acute promyelocytic leukemia, thus deepening his knowledge and experience in genetics.

Subsequently, Dr. Merghoub joined the Alan Houghton Laboratory as a Senior Research Scientist, where he began to study tumor immunity. He developed mouse models of melanoma that mimic different stages of human disease clinically, pathologically, and genetically. These models allowed him to evaluate new immunotherapies at different stages of tumor progression.

His career at Memorial Sloan Kettering Cancer Center saw remarkable progression. He first became an assistant attending biologist in the melanoma and sarcoma service, then assumed the direction of a research laboratory in partnership with Dr. Wolchok. He was subsequently promoted to associate attending in the melanoma and immunotherapeutic service, before becoming a full member of the Human Oncology and Pathogenesis Program (HOPP) department at MSK.

As a researcher member of the Parker Institute for Cancer Immunotherapy, he led the melanoma disease management team and the immunotherapeutic group tissue bank at MSK, thus contributing significantly to the advancement of research in this field.

In September 2022, Dr. Merghoub was appointed to his current position at Weill Cornell Medicine (WCM), where he directs a translational tumor immunology laboratory. His current research focuses on developing potential immune-based therapies to treat cancer. He is also studying the pathogenesis and treatment of melanoma, while developing tools to study melanoma and immune responses in various cancers. His work is characterized by strong collaboration within the institution and with multiple entities across different disciplines.

Distinctions & Recognition

Dr. Taha Merghoub's career is marked by international recognition of his expertise in cancer immunology and melanoma research. His appointment as deputy director of a major cancer center in the United States testifies to the recognition of his exceptional contributions in this field.

His scientific journey has been punctuated by publications in prestigious journals, and his work on mouse models of melanoma and tumor immunity mechanisms has significantly contributed to the advancement of knowledge in cancer immunotherapy.

His selection as a researcher member of the Parker Institute for Cancer Immunotherapy, a renowned institution in the field of immunotherapy, also constitutes an important recognition of his expertise and the impact of his research.

Impact & Influence

The impact of Dr. Taha Merghoub's work extends well beyond the laboratory, directly affecting the clinical management of cancer patients. His research in immunotherapy has helped transform the therapeutic landscape for melanoma and other cancers, offering new treatment options for patients who previously had limited prospects.

His current research projects, which revolve around four main axes, illustrate the breadth and depth of his influence in the field:

  • Overcoming resistance to immune checkpoint blockade therapy by modulating the immune system: this work aims to improve the efficacy of existing immunotherapies, thus offering new perspectives for patients who do not respond to standard treatments.
  • Using the immune modulatory properties of modalities that target and kill tumor cells directly: this innovative approach combines the advantages of targeted therapies and immunotherapy, thus maximizing therapeutic potential.
  • Defining biomarkers and genetic determinants of response to immune therapy: this research aims to personalize treatments based on the specific characteristics of each patient and their tumor, thus improving therapeutic outcomes.
  • Developing a tissue repository for the immunotherapy and melanoma groups: this initiative facilitates translational research by providing researchers with the biological resources necessary to study cancer biology and test new therapeutic approaches.

In addition to his direct scientific contributions, Dr. Merghoub plays a crucial role in training the next generation of researchers in cancer immunology and oncology. His expertise and mentorship influence many scientists and physicians who, in turn, will contribute to the advancement of knowledge and treatments in this field.

Furthermore, as a scientist of Algerian origin who has reached the highest levels in his field in the United States, Dr. Merghoub represents an inspiring model for young researchers, particularly those from developing countries. His journey illustrates how passion for science, coupled with determination and academic excellence, can transcend geographical and cultural boundaries to significantly contribute to the advancement of global medicine.

Learn More

To deepen your knowledge about Dr. Taha Merghoub's work, you can consult:

« Back